PAPER Sampognaro PJ, Vatsavayai SC, Cosme CG, Hwang JL, Nolan A, Huang EJ, Seeley WW, De May MG
SEARCH RESULTS
1219 RESULTS
PAPER Cikajlo I, Peterlin Potisk K
Advantages of using 3D virtual reality based training in persons with Parkinson's disease: a parallel study.
J Neuroeng Rehabil. 2019 Oct 17;16(1):119. PubMed: 31623622Alexandre Bejanin on Imaging Model Locates Epicenter of Disease, Predicts Atrophy
COMMENT Jesse Brown and colleagues combined healthy functional connectome with patient baseline MRI to predict individual patterns of longitudinal gray-matter atrophy in patients with behavioral variant frontotemporal dementia (bvFTD) and semantic variant primary
In-Hyun Park
Yale UniversityNew Haven, United States
PAPER Diaz-Castro B, Gangwani MR, Yu X, Coppola G, Khakh BS
Astrocyte molecular signatures in Huntington's disease.
Sci Transl Med. 2019 Oct 16;11(514) PubMed: 31619545PAPER Sinha A, Gindinova K, Mui E, Netzer WJ, Sinha SC
Development of Kinase Inactive PD173955 Analogues for Reducing Production of Aβ Peptides.
ACS Med Chem Lett. 2019 Oct 10;10(10):1430-1435. Epub 2019 Sep 6 PubMed: 31620229PAPER Adler CH, Serrano GE, Zhang N, Hinni ML, Lott DG, Mehta SH, Sue LI, Intorcia A, Beach TG
Feasibility of repeat and bilateral submandibular gland needle biopsies in Parkinson's disease.
Parkinsonism Relat Disord. 2019 Nov;68:69-72. Epub 2019 Oct 7 PubMed: 31621624PAPER Lamotte G, Holmes C, Wu T, Goldstein DS
Long-term trends in myocardial sympathetic innervation and function in synucleinopathies.
Parkinsonism Relat Disord. 2019 Oct;67:27-33. Epub 2019 Sep 16 PubMed: 31621602PAPER Rani K, Mukherjee R, Singh E, Kumar S, Sharma V, Vishwakarma P, Bharti PS, Nikolajeff F, Dinda AK, Goyal V, Kumar S
Neuronal exosomes in saliva of Parkinson's disease patients: A pilot study.
Parkinsonism Relat Disord. 2019 Oct;67:21-23. Epub 2019 Sep 9 PubMed: 31621600PAPER Mosley RL, Lu Y, Olson KE, Machhi J, Yan W, Namminga KL, Smith JR, Shandler SJ, Gendelman HE
A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease.
Front Cell Neurosci. 2019;13:421. Epub 2019 Sep 18 PubMed: 31619964PAPER Valdinocci D, Simões RF, Kovarova J, Cunha-Oliveira T, Neuzil J, Pountney DL
Intracellular and Intercellular Mitochondrial Dynamics in Parkinson's Disease.
Front Neurosci. 2019;13:930. Epub 2019 Sep 18 PubMed: 31619944PAPER Burbulla LF, Jeon S, Zheng J, Song P, Silverman RB, Krainc D
A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease.
Sci Transl Med. 2019 Oct 16;11(514) PubMed: 31619543PAPER Shefner J, Heiman-Patterson T, Pioro EP, Wiedau-Pazos M, Liu S, Zhang J, Agnese W, Apple S
Long-term edaravone efficacy in amyotrophic lateral sclerosis: Post-hoc analyses of Study 19 (MCI186-19).
Muscle Nerve. 2020 Feb;61(2):218-221. Epub 2019 Nov 11 PubMed: 31621933PAPER Mandrioli J, Amedei A, Cammarota G, Niccolai E, Zucchi E, D'Amico R, Ricci F, Quaranta G, Spanu T, Masucci L
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis.
Front Neurol. 2019;10:1021. Epub 2019 Sep 20 PubMed: 31620079PAPER Bartoletti M, Bosco DA, Da Cruz S, Lagier-Tourenne C, Liachko N, Markmiller S, Webster KM, Wharton KA
Phenotypic Suppression of ALS/FTD-Associated Neurodegeneration Highlights Mechanisms of Dysfunction.
J Neurosci. 2019 Oct 16;39(42):8217-8224. PubMed: 31619490Current Filters
- Date Range : Sep 2019 to Oct 2019 x